Sysmex ADR EBITDA 2016-2024 | SSMXY
Sysmex ADR annual and quarterly EBITDA history from 2016 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- Sysmex ADR EBITDA for the quarter ending December 31, 2024 was $0.170B, a 38.78% increase year-over-year.
- Sysmex ADR EBITDA for the twelve months ending December 31, 2024 was $0.669B, a 14.82% increase year-over-year.
- Sysmex ADR 2024 annual EBITDA was $0.757B, a 3.05% decline from 2023.
- Sysmex ADR 2023 annual EBITDA was $0.781B, a 7.53% decline from 2022.
- Sysmex ADR 2022 annual EBITDA was $0.844B, a 21.11% increase from 2021.
| Sysmex ADR Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $757 |
| 2023 | $781 |
| 2022 | $844 |
| 2021 | $697 |
| 2020 | $727 |
| 2019 | $694 |
| 2018 | $691 |
| 2017 | $572 |
| 2016 | $630 |
| Sysmex ADR Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2024-06-30 | $170 |
| 2023-06-30 | $158 |
| 2022-06-30 | $142 |
| 2021-06-30 | $199 |
| 2020-06-30 | $122 |
| 2019-06-30 | $155 |
| 2018-06-30 | $162 |
| 2017-06-30 | $143 |
| 2016-06-30 | $160 |
| 2016-03-31 | $585 |
| 2015-12-31 | $524 |
| 2015-09-30 | $526 |
| 2015-06-30 | $478 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $10.386B | $3.340B |
| Sysmex Corporation is engaged in the development, manufacture, import, export and sale of clinical laboratory instruments, reagents and software used in -vitro diagnostics. It also provides clinical laboratory testing of blood, urine and other specimens. The company's product includes instruments and reagents diagnostics for hemostasis, immunochemistry, clinical chemistry, urinalysis and point-of-care testing. Its operating segment consists of Japan, Americas, EMEA, China and Asia Pacific. Sysmex Corporation is headquartered in Kobe, Japan. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $180.170B | 21.80 |
| Intuitive Surgical (ISRG) | United States | $179.421B | 74.37 |
| Edwards Lifesciences (EW) | United States | $47.608B | 31.58 |
| IDEXX Laboratories (IDXX) | United States | $46.009B | 52.87 |
| Alcon (ALC) | Switzerland | $43.988B | 29.73 |
| DexCom (DXCM) | United States | $34.921B | 52.39 |
| IQVIA Holdings (IQV) | United States | $32.562B | 18.40 |
| Mettler-Toledo (MTD) | United States | $26.309B | 31.29 |
| STERIS (STE) | Ireland | $22.554B | 24.84 |
| Waters (WAT) | United States | $17.797B | 25.11 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.385B | 0.00 |
| Hologic (HOLX) | United States | $14.480B | 15.66 |
| Penumbra (PEN) | United States | $9.845B | 72.42 |
| Masimo (MASI) | United States | $8.459B | 31.20 |
| Globus Medical (GMED) | United States | $7.236B | 17.24 |
| Glaukos (GKOS) | United States | $5.374B | 0.00 |
| Teleflex (TFX) | United States | $5.034B | 8.31 |
| Integer Holdings (ITGR) | United States | $3.810B | 19.01 |
| TransMedics (TMDX) | United States | $3.643B | 55.80 |
| PROCEPT BioRobotics (PRCT) | United States | $2.841B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.400B | 14.29 |
| Nihon Kohden (NHNKY) | Japan | $1.956B | 22.43 |
| Elekta AB (EKTAY) | Sweden | $1.903B | 17.10 |
| Veracyte (VCYT) | United States | $1.877B | 26.34 |
| Alphatec Holdings (ATEC) | United States | $1.568B | 0.00 |
| Artivion (AORT) | United States | $1.348B | 126.28 |
| Tandem Diabetes Care (TNDM) | United States | $1.110B | 0.00 |
| OPKO Health (OPK) | United States | $1.063B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.991B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.961B | 5.11 |
| SiBone (SIBN) | United States | $0.759B | 0.00 |
| IRadimed (IRMD) | United States | $0.742B | 37.66 |
| Beta Bionics (BBNX) | United States | $0.727B | 0.00 |
| AxoGen (AXGN) | United States | $0.601B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.540B | 8.40 |
| OrthoPediatrics (KIDS) | United States | $0.527B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.495B | 10.66 |
| Pacific Biosciences Of California (PACB) | United States | $0.447B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.445B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.434B | 10.08 |
| Delcath Systems (DCTH) | United States | $0.381B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.364B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.348B | 0.00 |
| RxSight (RXST) | United States | $0.324B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.298B | 0.00 |
| Neuronetics (STIM) | United States | $0.294B | 0.00 |
| NeuroPace (NPCE) | United States | $0.287B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.246B | 0.00 |
| 908 Devices (MASS) | United States | $0.244B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.236B | 14.30 |
| CVRx (CVRX) | United States | $0.215B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.200B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.178B | 0.00 |
| Inogen (INGN) | United States | $0.176B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.174B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.166B | 0.00 |
| LENSAR (LNSR) | United States | $0.156B | 0.00 |
| Accuray (ARAY) | United States | $0.151B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.123B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.120B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.113B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.109B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.094B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.087B | 52.90 |
| EnVVeno Medical (NVNO) | United States | $0.085B | 0.00 |
| Hyperfine (HYPR) | United States | $0.079B | 0.00 |
| InspireMD (NSPR) | United States | $0.073B | 0.00 |
| Spectral AI (MDAI) | United States | $0.062B | 0.00 |
| Positron (POSC) | United States | $0.061B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.055B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.053B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.051B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.050B | 20.33 |
| WORK Medical Technology Group (WOK) | China | $0.044B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Envoy Medical (COCH) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.026B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.021B | 0.00 |
| NexGel (NXGL) | United States | $0.017B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.014B | 0.00 | |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.006B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 14.74 |